DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+9.69%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.51B
AUM Growth
+$465M
(+9.2%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-8.25%
Top 10 Holdings %
Top 10 Hldgs %
54.24%
Holding
168
New
43
Increased
28
Reduced
13
Closed
42
Top Buys
| 1 |
United Therapeutics
UTHR
|
$76.3M |
| 2 |
Merck
MRK
|
$67.9M |
| 3 |
Vera Therapeutics
VERA
|
$54.1M |
| 4 |
Legend Biotech
LEGN
|
$43.3M |
| 5 |
Centene
CNC
|
$27.9M |
Top Sells
| 1 |
Dynavax Technologies
DVAX
|
$67.3M |
| 2 |
Alignment Healthcare
ALHC
|
$59.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$40.4M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
$32.1M |
| 5 |
InMode
INMD
|
$28M |
Sector Composition
| 1 | Healthcare | 89.05% |
| 2 | Real Estate | 0.41% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cerus
CERS
$255M
| – | – |
-44,693
| Closed | -$62.1K |
|
127
CG Oncology
CGON
$2.52B
| – | – |
-850,695
| Closed | -$20.8M |
|
|
DHC
128
Diversified Healthcare Trust
DHC
$995M
| – | – |
-33,892
| Closed | -$81.3K |
|
|
129
Dynavax Technologies
DVAX
$1.18B
| – | – |
-5,191,493
| Closed | -$67.3M |
|
130
DXC Technology
DXC
$2.65B
| – | – |
-11,883
| Closed | -$203K |
|
131
Dyne Therapeutics
DYN
$2.02B
| – | – |
-812,408
| Closed | -$8.5M |
|
132
Establishment Labs
ESTA
$1.13B
| – | – |
0
| – | – |
|
|
FPI
133
Farmland Partners
FPI
$473M
| – | – |
-16,863
| Closed | -$188K |
|
134
GH Research
GHRS
$874M
| – | – |
-925,000
| Closed | -$10.2M |
|
135
Hallador Energy
HNRG
$733M
| – | – |
-13,713
| Closed | -$168K |
|
|
136
InMode
INMD
$947M
| – | – |
-1,578,708
| Closed | -$28M |
|
137
St. Joe Company
JOE
$2.96B
| – | – |
-4,473
| Closed | -$210K |
|
138
Lantheus
LNTH
$3.72B
| – | – |
-240,218
| Closed | -$23.4M |
|
139
MediaAlpha
MAX
$699M
| – | – |
-10,795
| Closed | -$99.7K |
|
|
MFA
140
MFA Financial
MFA
$1.07B
| – | – |
-10,935
| Closed | -$112K |
|
141
MannKind Corp
MNKD
$1.7B
| – | – |
-17,380
| Closed | -$87.4K |
|
142
MaxCyte
MXCT
$150M
| – | – |
-19,121
| Closed | -$52.2K |
|
143
Neurogene
NGNE
$285M
| – | – |
-446,880
| Closed | -$5.23M |
|
144
Nuvation Bio
NUVB
$1.33B
| – | – |
-45,448
| Closed | -$80K |
|
145
Olaplex Holdings
OLPX
$994M
| – | – |
-28,833
| Closed | -$36.6K |
|
146
Opko Health
OPK
$1.07B
| – | – |
-6,906,362
| Closed | -$11.5M |
|
147
Quanterix
QTRX
$211M
| – | – |
-11,023
| Closed | -$71.8K |
|
148
Ring Energy
REI
$207M
| – | – |
-127,376
| Closed | -$146K |
|
149
Repay Holdings
RPAY
$506M
| – | – |
-13,175
| Closed | -$73.4K |
|
150
Sunrun
RUN
$4.19B
| – | – |
-10,124
| Closed | -$59.3K |
|